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Surgical Management of Penile Cancer - Report of two cases
M. Amjad Noor,M. Hammad Ather,M Nasir Sulaiman,Farhat Abbas  ( Section of Urology, Department of Surgery, The Aga
Khan University Hospital. ) 
Introduction 
Penile carcinoma (PC) is a rare tumor, accounting for 0.4-0.6% of all male malignancies. There are
remarkable racial and geographic differences in the prevalence of penile cancer. In United States, 1% of
all male cancers are penile malignancies, with annual incidence of 1-2 new cases per 100,000 men. In
certain areas of South America, Asia and Africa the frequency is as high as 10-20% of all male cancers.
Many areas in Asia however, have very low figures; in Taiwan for example it comprised only 0.25% of
all male cancers1. Penile carcinoma is most frequent in uncircumcised males than in those circumcised
in infancy, for example: Non-Jewish versus Jewish population in the West1,2 and non-Muslim versus
Muslim population in India3,4. Circumcision at birth however, does not always protect an individual
from developing penile cancer5. Similarly circumcision beyond infancy is also not protective against
the development of penile cancer6. PC has also been noted in the scared penile shaft skin following
mutilating circumcision7.  A strong etiologic association of PC has been found between Human
Papilloma Virus (HPV), phimosis, paraphimosis, and balanitis5,8. Data from Asian countries indicates
that the risk of PC increases progressively beyond 30 years of age with the peak incidence in the 6-7th
decades of life9.
Some of the key factors complicating effective management of PC are the frequent delay in
establishing the diagnosis, controversy about lymph node dissection and patients wish for penile
conservation. The time from the initiation of signs and symptoms till the time the patient presents to a
physician is usually prolonged, resulting in rather advanced stage of the primary lesion6 at presentation.
This tends to adversely affect the treatment outcome of the disease.
In countries with very low incidence of PC, such as Pakistan, an average urologist rarely encounters
such cases. Combined with the existing controversies about optimum treatment strategies, it is
extremely difficult to develop management guidelines based on local experience. It therefore remains
important to report such uncommon cancer cases to enlarge the existing local data. This paper describes
2 cases of PC managed at a university hospital during the last three years.
Parameters assessed were clinical presentation, physical examination findings, radiological work up
and details of treatment offered. Patients were followed up for long term complications related to
cancer treatment and surgical morbidity. Based on personal experience and from review of
contemporary literature on the subject protocol for evaluation and treatment in the form of an algorithm
is also proposed.
Case 1
A 60-year old male, presented with a 10-year history of itching at glans penis and an ulcer on right side
of glans penis for the last 3 years. He suffered from diabetes mellitus and pulmonary tuberculosis and
was circumcised in late childhood. His initial evaluation outside Karachi revealed squamous cell
carcinoma (SCC) after biopsy of penile ulcer and was subsequently treated with chemotherapy and
radiation therapy (no documentation was available). However, within a year he developed a recurrent
ulcer at glans penis and presented to our outpatient clinic. His initial general and abdominal
examination was unremarkable except for bilaterally enlarged inguinal lymph nodes. A biopsy of the
glans penile ulcer revealed a moderately differentiated SCC. X-ray chest showed multiple opacities in
the right upper zone which on CT scan of chest, was suggestive of healed tuberculous lesions. CT
guided percutaneous biopsy of the pulmonary lesion also showed chronic inflammatory changes. MRI
of the penis (Figure 1)
was done to determine depth of tumor invasion and showed no cavernosal involvement. As the disease
was confined to the distal shaft, partial penectomy with preservation of 8 cm of un-involved proximal
penile shaft and bilateral sentinel lymph node biopsy was performed .The resected surgical margin and
both sided Sentinel lymph nodes were tumor free, the final pathologic stage was thus pT2NOMO. At
one year follow up, he remained free of tumor with no voiding difficulty.
Case 2
A 78-year old healthy male, farmer from northern areas of Pakistan, presented with a 4 month history
of swelling and pain in penile shaft and 2 month history’ of two ulcers on the ventral penile shaft
(Figure 2).
He was circumcised in late childhood and he had no lower urinary tract symptoms. He was initially
evaluated and treated for an infective penile ulcer outside Karachi. Apparently, he underwent some
minor surgical procedure and remained well for about a month following which the ulcer progressed to
a large ulcerative lesion.
Examination revealed a swollen and hard penis especially the glans penis. There were 2 hard, indurated
ulcerative lesions: one measuring 4 x 3 cms about 4 cm from the penoscrotal junction on the ventral
surface and, the other measuring 2 x I cms about 3 cm from the glans penis. Both ulcers had everted
margins and were covered with superficial slough. He had bilaterally enlarged inguinal lymph nodes,
which were discrete, hard and mobile. He initially underwent suprapubic cystostorny and biopsy of the
penile lesion that revealed keratinizing well differentiated infiltrating SCC. Metastatic workup with
chest x-ray, ultrasound abdomen and liver function tests, revealed distant disease and hence the tumour
was clinically staged as T3 N2 MO (Stage Ill according to AJCC) and was treated by total penectomy
and perineal urethrostomy. Resected margins of corpous spongiosum with right and left crura were
tumour free. He was given a six-week course of broad-spectrum antibiotics, following which m inimal
clinical regression of inguinal lymph nodes was noted. An MRI of pelvis and perineum (Figure 3)
revealed bilateral, multiple, large (>2 cm) matted inguinal and iliac group of lymph nodes suggestive of
loco-regional nodal involvement. Two months after the initial surgery, the patient underwent bilateral
inguinal lymph node biopsy of well defined enlarged lymph nodes, which on frozen section, only
revealed reactive changes with no evidence of metastasis. At 3-months, he remains free of tumor
recurrence and would be regularly followed.
Discussion 
The most common histological type of PC is squamous cell carcinoma with the rare occurrence of basal
cell carcinoma, melanoma and Kaposi’s sarcoma. Common sites of involvement in descending order
are glans. prepuce and shaft. It is important that. the advanced and proximal lesion need to be
dilierentiated from extensive, ulcerative urethral cancer. Recently it has been suggested that both
Bowen’s disease and Ervthroplasia of Queyrat should be considered as penile carcinoma in situ rather
than as premalignant conditions10.
The tumour begins as an area of induration, erythema, warty growth. nodule, or as superficial
ulceration. The most important prognostic factor in patients with penile cancer is the status of regional
lymph nodes, which in turn are related to the depth of tumor invasion and histologic grade9,11-13
Metastasis to distant sites such as liver, lung. and brain is seen only in 5% of patients at the time of
diagnosis14. Assessment of the depth of invasion of the primary lesion by means of deep tissues biopsy
is necessary in all cases to plan an appropriate management. Magnetic resonance imaging is now the
investigation of choice for assessment of local extent of the tumor15,16.
In the absence of distant metastasis, surgical management of penile cancer is dependent on the depth.
extent of the primary lesion and the status of the regional lymph nodes (Table).
The goal of local treatment is complete removal of’ the primary lesion with 1.5 cms or more of healthy
resected margins17. While partial or total penectomy remains the gold standard, various other
approaches have been used especially in small lesions when organ conservation is an important
consideration18. The experience with conservative surgery is however, limited and carries the risk of
local and regional recurrence24. Partial jenectomy serves well for distal TI and T2 lesions with 80% 5
years survival rate in the absence of inguinal lymph node metastases, Similarly, for more proximally
penile shaft and T3 lesions, total penectomy and perineal urethrostomy provides excellent cancer
control with 90% 5-year survival rates in the absence of distant metastasis The a Item ate approaches
include Moh’s  micrographic ic surgery which is only indicated for small distally located lesions upto 1
cm in diameter laser therapy (C02 or Nd: YAG) for TI and T2 lesions with 89% 5 year survival rate,
and radiation therapy for TI and T2 lesions . In tumors 4 cm or less in size with no or minor corporeal
invasion, interstitial radiation therapy has been shown to provide satisfactory local control with good
functional results20,21. Rarely, major exenterative surgery such as hem ipelvectomy and
hemicorporectomy could be used for T4 lesions with fixed nodes18.
The treatment of PC is dependent on the degree of local invasion and the status of regional lymph
nodes. While the treatment of primary penile cancer is well standardized, the major issue in its
management is the decision for lymph node dissection22. The problem arises due to inaccuracy of
clinical or radiological staging and marked morbidity associated with inguinal
lymphadenectomy11,23,24. Since PC is mostly a locoregional disease, inguinal/pelvic lymphadenectomy
in the absence of distant metastasis, has been shown to improve the cancer control rates. However, only
50% of patients with palpable inguinal lymph nodes would have metastasis. Conversely, about 20% of
patients with negative inguinal nodes would have occult metastasis20. Thus, in patients with clinically
negative nodes, it remains controversial whether to perform immediate prophylactic lymphadenectomy,
selective sentinel or Catalona lymph node biopsy or adopt a surveillance approach with delayed
lymphadenectomy when adenopathy is detected. Surveillance is definitely not indicated if the patient
cannot be reliably followed. The sentinel lymph node biopsy has a significant false negative rate of
about 25%25 whilst doubts have also been raised about Catalona procedure26.
Since about 50% of those with clinically positive nodes show no neoplastic involvement, patients
presenting with enlarged inguinal nodes should undergo treatment of the primary lesion followed by a 4
to 6 week course of oral broad-spectrum antibiotics. Those with complete resolution of
lymphadenopathy may be observed, while the others who persist to have palpable node need loco-
regional lymphadenectomy when there is absence of distant metastasis.
The information on chemotherapy for regionally advanced or metastatic penile cancer is limited.
Preliminary data indicates some response to combination therapy with cisplatin. bleomycin.
methotrexate and 5 Fluorouracil27-30.
Radiation therapy is ideal for patients with TI and T2 primary cancers of the penis. Pre-operative RT is
useful for patients with mobile lymph nodes> or = 4 cm in size in the groin. RT provides effective
palliation in patients with advanced regional disease and/or distant m etastases31,32.
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